All time low for Alexza Pharma... I'M HAVING A PANIC ATTACK
June 10, 2008
– Comments (4) |
RELATED TICKERS: ALXA
Heres a link to the dissapointing recent news about Alexza Pharmacueticals clinical trials
And heres the jist of it:
"Alexza Pharmaceuticals, Inc. announced today preliminary results from its Phase 2a proof-of-concept clinical trial with AZ-002 (Staccato® alprazolam) in patients with panic disorder. The study did not meet its two primary endpoints, which were the effect of AZ-002 on the incidence of a doxapram-induced panic attack and the effect of AZ-002 on the duration of a doxapram-induced panic attack, both as compared with placebo."
A little background:
Alprazolam is Xanax for those who don't know. Xanax is a great drug for people with panic attacks and anxiety, it works nicely and it massively prescribed, the problem is, for people with acute panic attacks, the pill just doesn't act quickly enough.
So whats quicker than eating a pill? Inhaling a drug, as anyone who's every smoked heroin will tell you, is the fastest way to feel the effects, even faster than injecting the drug (since the blood passing through the lungs goes directly to the brain, and the blood passing through a vein has to travel around the body once before getting the brain). So the main idea behind ALXA's Staccato® system is sound science. Why the trail was a failure, I'm not entierly certain, but I don't think its a big a setback as it seems.
ALXA has the patent on the process, which can be applied to far more drugs than just Alprazolam. The two big ones that I think will be the money ones are fentanyl (a powerful synthetic opiate for pain) and zaleplon (for insomnia), both of which are currently still in Phase 1 trails. If they both make it to market, I think ALXA will be in the money. The company is solid, with good product on the horizon, and a patent on a system that may well become hugely popular, thats why I think right now, with ALXA at its all time low, is prime time to buy.